NCT03908294View on ClinicalTrials.gov

Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Glucose Metabolism DisordersLiver FibrosisHepatitis C
Interventions
DIAGNOSTIC_TEST

Lab tests, non-invasive fibrosis (Fibroscan/ARFI)

Patient characteristics, lab values reflecting glucose metabolism and non-invasive fibrosis tests are documented at baseline, during therapy and up to one year after end of treatment.

Trial Locations (1)

Unknown

Klinikum der J. W. Goethe-Universität, Frankfurt am Main

All Listed Sponsors
lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT03908294 - Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents | Biotech Hunter | Biotech Hunter